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Mosquito-borne flaviviruses, including yellow fever virus (YFV), Zika
virus (ZIKV), and West Nile virus (WNV), profoundly affect human
health. The successful transmission of these viruses to a human host
depends on the pathogen’s ability to overcome a potentially sterilizing
immune response in the vector mosquito. Similar to other invertebrate
animals and plants, the mosquito’s RNA silencing pathway comprises
its primary antiviral defense. Although a diverse range of plant and
insect viruses has been found to encode suppressors of RNA silencing,
the mechanisms by which flaviviruses antagonize antiviral small RNA
pathways in disease vectors are unknown. Here we describe a viral
suppressor of RNA silencing (VSR) encoded by the prototype flavivirus,
YFV. We show that the YFV capsid (YFC) protein inhibits RNA silencing
in the mosquito Aedes aegypti by interfering with Dicer. This VSR
activity appears to be broadly conserved in the C proteins of other
medically important flaviviruses, including that of ZIKV. These results
suggest that a molecular “arms race” between vector and pathogen
underlies the continued existence of flaviviruses in nature.
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Arthropod-borne viruses (arboviruses) are maintained in na-ture through transmission cycles that involve alternating
replication in hematophageous insect vectors and vertebrate hosts.
The Flavivirus genus of the family Flaviviridae contains a number of
important mosquito-borne viruses responsible for large epidemics
of human disease. These include Zika virus (ZIKV), West Nile virus
(WNV), dengue virus (DENV; serotypes 1–4), Japanese encepha-
litis virus (JEV), and the type virus for the family, yellow fever virus
(YFV). The YFV genome is a single-stranded RNA of positive
polarity that is ∼11 kb in length. The 5′-capped RNA encodes the
structural proteins (C-prM-E) and nonstructural proteins (NS1-
NS2A-NS2B-NS3-NS4A-2K-NS4B-NS5) (1). Nonstructural com-
ponents are assembled, with host factors, into membrane-bound
replication complexes, where the various enzymatic functions of
these proteins (e.g., RNA-dependent RNA polymerase, helicase,
capping machinery) replicate the genome. The relatively smooth
surface of the flavivirus virion is decorated with the envelope (E)
and membrane (M) proteins, anchored into the host-derived lipid
bilayer via C-terminal transmembrane domains. Within the virion is
a nucleocapsid core comprising a single copy of the RNA genome
in complex with multiple capsid (C) proteins (2–4). In an urban
transmission cycle, the yellow fever mosquito, Aedes aegypti, ac-
quires the virus after feeding on an infected human host. After a
brief incubation period, the mosquito may transmit the virus to
other susceptible humans. Although infection of the vertebrate
human host is often associated with pathology and disease, a per-
sistent nonlethal infection is established in the insect vector.
When vector mosquitoes become infected with arboviral patho-
gens, antiviral immunity is essential to the survival of the insect (5).
Although a sufficiently robust immune response may be sterilizing,
the antiviral defenses of the mosquito are not always an effective
barrier to the transmission of viral pathogens. In plant and in-
vertebrate organisms, double-stranded RNA (dsRNA) replicative
intermediates (RIs) produced during viral infection activate an an-
tiviral defense based on RNA silencing (6). In flies, the ribonuclease
Dicer-2 (Dcr-2) recognizes dsRNA (7). Cleavage of dsRNA RIs by
Dcr-2 generates viral small interfering RNAs (vsiRNAs) ∼21 nt in
length. These siRNA duplexes are incorporated into the RNA-
induced silencing complex (RISC). RISCmaturation involves loading
a duplex siRNA, choosing and retaining a guide strand, and ejecting
the antiparallel passenger strand (8–11). The guide strand directs
Argonaute 2 (Ago-2), an essential RISC component possessing en-
donuclease activity, to complementary RNAs in the cell, leading to
their sequence-specific degradation. When infected with RNA
viruses, Drosophila melanogaster dcr-2 or ago-2 loss-of-function mu-
tants exhibit an “enhanced disease phenotype,” characterized by
elevated levels of virus replication and increased mortality (12–14).
In an evolutionary “arms race,” the genomes of numerous plant
and insect viruses have evolved to encode one or more viral
suppressors of RNA silencing (VSRs) (15, 16). For example, the
flock house virus (FHV) B2 is a well-characterized dsRNA-binding
protein that shields the RIs produced during viral infection from
processing by Dcr-2 and interferes with the incorporation of
vsiRNA duplexes into the RISC (17–20). Well-documented ex-
amples of plant and insect virus proteins that interfere with small
RNA pathways suggest that arboviruses may encode similar
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proteins; however, the mechanisms by which medically important
arboviruses modulate small RNA pathways to productively infect
disease vectors remain unknown. Elucidating these mechanisms
would fundamentally alter our understanding of pathogen trans-
mission by arthropod vectors.
We have previously shown that an antiviral response directed
by vsiRNAs is essential to limiting the pathogenesis of arbovirus
infections in mosquitoes (5). Suppressing the accumulation of
vsiRNAs in Ae. aegypti by infection with a recombinant Sindbis
virus (SINV) expressing the FHV B2 resulted in elevated levels
of virus replication and increased mortality, i.e., a disease phe-
notype. In the present study, we show that this phenotype can be
used to reliably identify VSRs that interfere with RNA silencing
by diverse mechanisms. Thus, to investigate the possible pres-
ence of VSRs encoded in the genomes of flaviviruses and other
mosquito-borne pathogens, we infected Ae. aegypti with recombi-
nant SINVs (Alphavirus genus) expressing heterologous virus se-
quences. Here we report suppression of RNA silencing in Ae. aegypti
mosquitoes infected with a recombinant SINV expressing the yellow
fever virus capsid (YFC). Furthermore, through a series of bio-
chemical assays, we demonstrate that the observed antagonism
of RNA silencing is mediated by the binding of YFC to long
dsRNAs, interfering with the production of vsiRNAs by Dicer.
Finally, we provide evidence that this VSR activity is broadly
conserved in the C proteins of other medically important flavi-
viruses, including that of ZIKV.
Results
Studies identifying VSRs have often been guided by previous
experimental evidence implicating a particular viral protein or
sequence as a virulence factor. Infection of an invertebrate host
with arboviruses tends to be avirulent, however, making the
identification of VSR activity in these viruses more challenging.
We previously showed that expression of FHV B2 protein from
recombinant alphaviruses dramatically increases the virulence of
infection in the mosquito host, resulting in a disease phenotype
(5). We hypothesized that this phenotype would be predictive of
VSR functions in other viral proteins and sequences.
As an initial test of this hypothesis, we created recombinant SINVs
expressing well-characterized VSR proteins from a duplicated sub-
genomic promoter (Fig. 1A). Ae. aegypti mosquitoes were infected
with SINVs expressing the Cricket paralysis virus 1A protein (SINV/
CrPV-1A) (12, 21), D. melanogaster C virus 1A protein (SINV/DCV-
1A) (14), Carnation Italian ringspot tombusvirus P19 protein (SINV/
CIRV-P19) (22–24), or the influenza A virus NS1 protein (SINV/
H1N1-NS1) (25–27). Control viruses were engineered to contain
nontranslatable versions of these proteins expressed from the second
subgenomic promoter. We previously showed that the survival of
Ae. aegypti infected with recombinant SINV is indistinguishable from
that of uninfectedmosquitoes (5). In the present experiment, however,
mortality was significantly higher in Ae. aegypti infected with SINV/
CrPV-1A, SINV/DCV-1A, SINV/CIRV-P19, or SINV/H1N1-NS1
compared with mosquitoes infected with SINV or control viruses
expressing nontranslatable transcripts (Fig. 1B). These results suggest
a strong correlation between the expression of heterologous VSR
proteins and a disease phenotype in mosquitoes infected with SINV,
even under circumstances in which the heterologous VSRs are de-
rived from a diverse range of viruses employing different mechanisms
of RNA interference (RNAi) suppression.
We next tested whether the expression of candidate VSRs,
previously identified in the genomes of WNV, DENV, and
Bunyamwera virus (BUNV; Orthobunyavirus genus), correlated
with a disease phenotype in mosquitoes infected with SINV.
Ae. aegypti were infected with viruses expressing the WNV
sfRNA (SINV/WNV-sfRNA) (28), DENV NS4B protein (SINV/
DENV-NS4B) (29), or BUNV NSs protein (SINV/BUNV-NSs)
(30). Control viruses expressed inactive mutant versions of the
WNV sfRNA or BUNV NSs protein, containing the previously
described deletions sfRNA IRA (31) or delNSs (30), respectively.
In contrast to the results described above, there was no significant
difference between the survival of mosquitoes infected with con-
trol viruses and those infected with SINV/WNV-sfRNA, SINV/
DENV-NS4B, or SINV/BUNV-NSs (Fig. 2A). Real-time PCR
(RT-PCR) analysis of SINV RNA in the infected mosquitoes
corroborated the survival results, indicating no significant increase
in levels of virus replication in mosquitoes infected with SINV/
WNV-sfRNA, SINV/DENV-NS4B, or SINV/BUNV-NSs com-
pared with mosquitoes infected with control viruses (Fig. 2B).
These results suggest that the WNV sfRNA, DENV NS4B, and
BUNV NSs provide little to no protection from an RNA silencing
response induced by virus replication in Ae. aegypti.
Whereas a disease phenotype is evident in mosquitoes infected
with alphaviruses expressing heterologous VSRs, similar exper-
iments had not been performed with flaviviruses. Therefore, we
assessed the replication of YFV in Ae. aegypti in which Dicer-2
has been genetically ablated (32). Our results show that the
replication of YFV is significantly higher in dcr-2 null mutant
mosquitoes compared with wild type (WT) mosquitoes at the
same time point, suggesting that RNAi is an important antiviral
mechanism targeting flaviviruses in the vector host (Fig. S1).
Although not a feature of all VSRs, dsRNA binding is essential
to the antiviral activity of many well-characterized proteins that
interfere with small RNA pathways (14, 17–19, 22–27, 33, 34).
Even though a dsRNA-binding function has not previously been
assigned to the flavivirus capsid, the protein has physical proper-
ties common to other VSRs that indiscriminately bind dsRNAs,
shielding them from Dicer and RISC assembly; for example, evi-
dence indicates that the flavivirus capsid protein binds RNA
through nonspecific electrostatic interactions (35, 36), similar to
FHV B2 (17–20) and Influenza A virus NS1 (25–27). Therefore,
we assessed the potential of the YFC protein to act as an antag-
onist of antiviral immunity in the disease vector host. To do so,
we infected Ae. aegypti with a virus expressing the YFC protein
(SINV/YFC) or a control virus containing a nontranslatable ver-
sion of the protein-coding sequence (SINV/YFC-NTR). Similar to
the results obtained with well-known VSR proteins, mortality was
Fig. 1. A disease phenotype in Ae. aegypti infected with recombinant SINVs
expressing heterologous VSR proteins. (A) Schematic of a recombinant SINV
expressing a VSR from an engineered subgenomic promoter (SG2). (B) Sur-
vival of mosquitoes after infection with recombinant SINVs expressing well-
known VSR proteins (red triangles) or with viruses containing non-
translatable versions of the VSR sequences (black circles). Survival curves
represent cohorts of ≥40 adult female mosquitoes injected with 500 pfu of
virus. Significance was determined using the Mantel–Cox log-rank test.
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significantly higher in mosquitoes infected with SINV/YFC compared
with those infected with the virus containing the nontranslatable
version of the protein-coding sequence (Fig. 3A). Also consistent with
a disease phenotype, RT-PCR analysis indicated significantly higher
levels of virus replication in mosquitoes infected with SINV/YFC
compared with those infected with SINV/YFC-NTR (Fig. 3B).
To confirm that the observed disease phenotype in mosquitoes
infected with SINV/YFC is due to a specific VSR activity present
in the expressed YFV capsid, and not to some other function of
the protein, we infected dcr-2 null mutant Ae. aegypti defective for
the production of vsiRNAs with the recombinant SINVs (32). Not
surprisingly, dcr-2 null mutant mosquitoes infected with the con-
trol virus also exhibited a disease phenotype, as would be expected
in the absence of a functional siRNA pathway (12–14). However,
in contrast to infections of the WT mosquitoes, survival curves for
the dcr-2 mosquitoes infected with SINV/YFC or SINV/YFC-
NTR were remarkably similar, indicating that in the absence of
the primary antiviral response, the expression of YFC did not
dramatically enhance virus pathogenicity (Fig. 3C). Consistent
with this, the replication of SINV/YFC-NTR did not differ sig-
nificantly from that of SINV/YFC in the mutant mosquitoes (Fig.
3D), indicating that the dcr-2 null genotype genetically rescued
replication of the control virus. Overall, these experiments suggest
VSR activity in YFC capable of suppressing RNA silencing in the
natural disease vector host, Ae. aegypti.
Because small RNAs ultimately serve as the effector molecules
that direct the sequence-specific degradation of cognate target
RNAs in the cell, we next analyzed the ratio of viral small RNAs
(through Illumina-based sequencing) to viral RNAs in mosquitoes
infected with recombinant SINVs (Fig. 3B and Fig. S2). The
number of vsiRNAs targeting SINV/YFC decreased approximately
fourfold compared with those targeting SINV/YFC-NTR in a WT
genetic background (Fig. 4A), suggesting that the VSR activity of
YFC is mediated by specific inhibition of Dicer. Thus, to further
characterize the VSR activity of the YFV capsid, we expressed and
purified a polyhistidine-tagged (His-tag) YFC protein (His-YFC)
from Escherichia coli.
To assess the effect of His-YFC on the processing of a dsRNA
substrate into siRNAs, we performed in vitro dicing assays. In
the absence of His-YFC, dsRNA was efficiently processed into
siRNAs by the recombinant Dicer enzyme (Fig. 4B, lanes 1
and 2); however, addition of His-YFC to the in vitro dicing assay
inhibited the production of siRNAs in a dose-dependent manner
(Fig. 4B, lanes 3–5). Similarly, His-tagged influenza A virus NS1,
a well-characterized dsRNA-binding protein with previously
demonstrated VSR activity (25–27), also inhibited dicing of the
dsRNA substrate in this assay (Fig. 4B, lanes 6–8). In contrast, an
unconjugated His-tag peptide or a green fluorescent protein
(GFP) had no effect on the activity of Dicer (Fig. 4B, lanes 9 and
10). These results confirm that YFC inhibits cleavage of dsRNA
substrates by Dicer.
To determine whether the mechanism of Dicer inhibition by the
YFC is similar to that of NS1 (i.e., nonspecific binding to dsRNAs)
(25–27), we performed electrophoretic mobility shift assays
(EMSAs) with both a long dsRNA and a 21-bp duplex siRNA.
Although YFC was able to bind the longer dsRNA with high affinity
(Fig. 4C), there was little evidence of interaction of the recombinant
protein with the shorter duplex siRNA (Fig. 4D), suggesting that
YFC does not interfere with loading of the RISC. Whereas there
was an observable shift in the mobility of both the long dsRNA and
the duplex siRNA with the recombinant NS1 protein, there was no
interaction of either RNA with the unconjugated His-tag, even at
the equivalent highest concentration. Finally, we also observed
binding of YFC with long ssRNAs derived from YFV or luciferase
sequences (Fig. S3), indicating that the recombinant protein is able
Fig. 2. Infection of Ae. aegypti with recombinant
SINVs expressing heterologous sequences with sus-
pected VSR activity. (A) Survival after infection with
recombinant SINVs expressing suspected VSRs (red
triangles) or with control viruses (black circles). Sur-
vival curves represent cohorts of ≥40 adult female
mosquitoes injected with 500 pfu of virus. Significance
was determined using the Mantel–Cox log-rank test.
(B) RT-PCR results demonstrating accumulation of viral
RNA in mosquitoes infected with recombinant SINVs
expressing suspected VSR proteins or control viruses.
Error bars indicate the SEM among three biological
replicates (n = 5 per replicate).
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Fig. 3. The YFV capsid is a suppressor of RNA silencing. (A and C) Survival
curves for Liverpool strain WT Ae. aegypti (A) and dcr-2 null mutant mos-
quitoes (C) infected with either recombinant SINV expressing YFC (red tri-
angles) or virus containing a nontranslatable version of the YFC sequence
(black circles). Survival curves represent cohorts of ≥30 adult female mos-
quitoes injected with 500 pfu of virus. (B and D) Accumulation of viral RNA in
WT mosquitoes (B) and dcr-2 mutants (D) infected with recombinant SINV
expressing YFC or virus containing a nontranslatable YFC sequence. Error
bars for RT-PCR results indicate the SEM among three independent bi-
ological replicates (n = 5 per replicate).
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to bind nonspecifically to both dsRNAs and ssRNAs. Overall, these
results demonstrate that YFC has a dsRNA-binding function that
interferes with the cleavage of long dsRNAs by Dicer.
To investigate a possible correlation between the expression of
other flavivirus C proteins and a disease phenotype in mosquitoes
infected with SINV, we generated recombinant SINVs expressing
the capsid of ZIKV (SINV/ZIKC), WNV (SINV/WNC), DENV-2
(SINV/DENC), or Rio Bravo virus (RBV; SINV/RBC). Com-
pared with Ae. aegypti infected with SINV/YFC-NTR, mosquitoes
infected with the recombinant SIN viruses expressing the heter-
ologous C proteins exhibited evidence of viral pathogenicity (Fig.
5). Given that these experiments included the C proteins of the
genetically distant ZIKV, DENV-2 (vectored by Ae. aegypti),
WNV (vectored by culex species mosquitoes), and a representa-
tive of the group of flaviviruses without any known vector, RBV
(isolated from bats) (37), these results strongly suggest that the
VSR activity identified in the YFC is broadly conserved in the C
proteins of other flaviviruses as well.
Discussion
Although many questions remain regarding the role of mammalian
small RNA pathways in antiviral defense, it is clear that the pres-
ence of conserved antiviral silencing pathways in invertebrate or-
ganisms plays an important role in the transmission of agents of
human disease. Mosquito-borne viruses are responsible for a broad
spectrum of human diseases, including arthritis, hemorrhagic fever,
encephalitis, and recently microcephaly and Guillain-Barré syn-
drome. Members of the Flavivirus genus, such as ZIKV, WNV,
DENV 1–4, JEV, and YFV, are among the most important mos-
quito-borne pathogens because of their widespread prevalence and
the severe morbidity and mortality they cause in humans. Trans-
mission of these viruses to human or animal hosts depends on the
pathogen’s ability to overcome the potentially sterilizing RNAi-based
immune response of the mosquito vector; however, the specific
mechanisms by which this may occur remain unknown.
There are numerous examples of VSRs encoded in the ge-
nomes of plant and insect viruses, which presumably evolved as a
result of an evolutionary arms race with antiviral silencing path-
ways (15, 16). However, for various reasons, interrogating mos-
quito-borne viruses for the presence of VSR proteins has proven
challenging. In this paper, we describe a simple but effective assay
that is highly informative with respect to identifying VSR functions
in proteins and other sequences. With this assay, we have identi-
fied a VSR encoded in the genome of YFV, the prototype flavi-
virus. Results obtained both in vivo and in vitro indicate that the
YFC protein antagonizes RNA silencing by binding long dsRNAs
with high affinity, interfering with efficient processing by Dicer.
Our studies also suggest that this VSR function is broadly con-
served among flavivirus C proteins.
Precedent for a VSR function in a viral structural protein can be
found in the coat protein (CP) of Turnip crinkle virus, which has
been shown to suppress RNA silencing through a mechanism that
likely also involves the binding of dsRNAs (38). In comparison
with other positive-strand viruses, the flavivirus nucleocapsid has a
poorly defined and unique architecture (2, 3, 39). Reported pro-
duction of noninfectious virus-like particles by overexpressing only
precursor membrane (prM) and E protein indicates that the C
protein is not required for formation of the virion’s spherical shell
(40, 41). Indeed, there appears to be little interaction between the C
protein and the E and M proteins, raising questions about how
nucleocapsids are efficiently incorporated into budding mem-
branous structures containing the flavivirus surface proteins (42). A
packaging signal has not been identified in genomes of flaviviruses,
and in vitro formation of nucleocapsid-like particles with positive-
or negative-stranded DENV RNAs of differing lengths is consistent
Fig. 4. The YFV capsid binds dsRNA and interferes with Dicer processing.
(A) Fold change in the ratio of viral small RNAs to viral mRNAs in mosquitoes
infected with recombinant SINVs, calculated from normalized small RNA reads
mapping to the viral genome and strand-specific RT-PCR analysis of SINV plus-
strands in 1 μg of total RNA. (B) An in vitro dicing assay with radiolabeled 700 bp
dsRNA, recombinant human Dicer, and increasing concentrations of His-YFC
(lanes 3–5) or His-NS1 (lanes 6–8). A His-tag peptide and GFP served as negative
controls (lanes 9 and 10). Products of the dicing assay were analyzed on a 15%
PAGE gel with a lowmolecular weight size marker. Lane 1, dsRNAwith reaction
buffer; lane 2, dsRNA with reaction buffer and recombinant Dicer. The con-
centrations of His-YFC and His-NS1 were 0.075 in lanes 3 and 6, 0.03 in lanes 4
and 7, and 0.015 nM in lanes 5 and 8; concentrations for the His-tag and GFP
were 0.075 nM in lanes 9 and 10, respectively. (C) EMSA with 200-bp dsRNA
(lane 1) and increasing concentrations of His-YFC protein (lanes 2–4), His-NS1
(lanes 5–7), and His-tag peptide (lane 8). RNA mobility shift was visualized with
SYBR Green on a 1% agarose gel. The concentrations of His-YFC and His-NS1
used were 0.03 (lanes 2 and 5), 0.06 (lanes 3 and 6), and 0.12 nM (lanes 4 and 7).
The concentration of His-tag used was 0.12 nM (lane 8). (D) EMSA with 21-bp
duplex siRNA (lane 1) and increasing concentrations of His-YFC protein (lanes 2–4),
His-NS1 (lanes 5–7), and His-tag peptide (lane 8). The concentrations of His-
YFC and His-NS1 were 0.03 nM (lanes 2 and 5), 0.06 nM (lanes 3 and 6), and
0.12 nM (lanes 4 and 7). The concentration of His-tag was 0.12 nM (lane 8).
Fig. 5. A disease phenotype in Ae. aegypti infected with recombinant SIN
viruses expressing flavivirus capsid proteins. Shown are survival curves for
mosquitoes infected with recombinant SIN viruses expressing flavivirus
capsid proteins (red triangles). Significance was determined by comparing
curves with the survival of mosquitoes infected with recombinant SINV
containing a nontranslatable YFC (black circles; replicated for each panel
from Fig. 3A) using the Mantel–Cox log-rank test. Survival curves represent
cohorts of ≥40 adult female mosquitoes injected with 500 pfu of virus.
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with the idea that these sequences do not exist (36). Rather, in-
teractions between RNA and the C protein appear to be mediated
by nonspecific electrostatic interactions (35, 36), and our results are
consistent with this idea. Evidence indicates that packaging requires
active synthesis of viral RNA, suggesting that replication and
encapsidation are tightly coupled (43). This may explain the ap-
parent specificity with which genomic RNA is packaged into the
virion, despite a lack of organization in the way in which C proteins
and viral RNA assemble (2, 3, 39). Our results, presented here,
suggest that the C protein interacts with viral dsRNA RIs in the
infected cell.
Similar to other positive-strand viruses, the replication com-
plexes of flaviviruses are believed to assemble on internal cellular
membranes (42). In DENV-infected cells, this process involves
extensive rearrangements of the endoplasmic reticulum to form
a continuous network of vesicles consisting of series of invagi-
nations of the endoplasmic reticulum membrane (44). Similar
structures have been observed in mosquito cells infected with
DENV (45). Detection of dsRNA within membrane vesicles
suggests that these are sites of viral replication within the in-
fected cell (44, 45). Although evidence suggests that membrane
vesicles are connected to the cytosol by pores (44, 45), it has been
postulated that these structures may protect the viral RNA from
the cellular components of innate immunity (46). However, the
existence of VSRs encoded in the genomes of flaviviruses sug-
gests that replication complexes are accessible to RNA silencing
pathways, and possibly other antiviral responses as well.
In mammalian cells, viral infection induces the synthesis and
secretion of type I IFNs (α/β). Activation of signaling pathways by
the secreted IFN results in the transcription of hundreds of genes,
contributing to the establishment of a general antiviral state in the
cell. A number of viruses have been found to express proteins that
are antagonists of the IFN α/β response. Similar to VSR proteins,
viruses have evolved diverse mechanisms for inhibiting the IFN
α/β response (47). Also similar to VSR proteins, dsRNA binding is
a molecular mechanism by which some viral proteins inhibit the
IFN α/β system. For example, the dsRNA-binding function of the
influenza NS1 protein counteracts the establishment of an anti-
viral state in the cell by blocking virus-mediated activation of
cellular transcription factors that induce synthesis of IFN α/β (26,
27, 47). Thus, a particularly intriguing possibility is that the
dsRNA-binding domain of the flavivirus capsid protein evolved to
counteract immune responses in both mammalian and insect
hosts. Conservation of a dsRNA-binding function in the C pro-
teins of flaviviruses without a known insect vector, as our data
suggests, justifies future studies to address the possibility that
flavivirus C proteins inhibit the type I IFN response.
Although flavivirus C proteins have low sequence identity, several
functional elements appear to be well conserved (48), for example,
the oligomeric state of the protein, which forms a dimer in solution
(49, 50). The individual subunits of the dimer each comprise four
alpha helices (α1–α4). The dimer conformation is stabilized through
hydrophobic interactions occurring between two pairs of antipar-
allel helices (50). The flavivirus C protein is highly basic, with
positively charged residues distributed throughout. The nonuniform
distribution generates an unusually large net positive charge that
makes the oligmerization of protein-only cores unlikely, which is
consistent with the the role of flavivirus C protein in RNA binding
and encapsidation (50). In vitro experiments have implicated the
first 32 and last 26 residues of the Kunjin virus (KUNV) C protein
as important in RNA binding (51); however, studies mapping the
minimal functional elements of the dimeric YFC protein required
for packaging and virus assembly have demonstrated remarkable
functional flexibility at the N and C termini of the protein (48).
Removal of the first 40 amino acid residues from the N ter-
minus, including the entire α1 helix, fail to abolish the C pro-
tein’s ability to package replicon RNA. Similarly, the last 27
residues of the YFC protein’s terminus, including complete
deletion of the α4 helix, are also expendable for virus assembly.
These findings have led to the proposal that genomic RNA is
bound initially at the N terminus of the C protein, followed by
binding of residues at the C terminus (48). However, the YFC
protein’s C terminus appears to be sufficient for packaging of
genomic RNA in the absence of binding sites located in N ter-
minus and vice versa (48). In future studies, it will be interesting
to determine whether the dsRNA-binding domain present in the
YFC is independent, identical, or overlaps with domains already
implicated as important to the binding of genomic RNA.
With rare exceptions, all cellular organisms have evolved a
system of protection from foreign genetic material (52). In re-
sponse, viruses have evolved to encode a diverse array of coun-
termeasures, composing the majority of genes in some viral
genomes, with the complete catalog constantly updated (52).
Evolutionary history is replete with examples of antiviral mecha-
nisms being co-opted by the cell for other functions (52); indeed, a
similar process is likely to have occurred in the small genomes of
RNA viruses, leading to the evolution of multifunctional proteins.
The establishment of persistent nonlethal infections in the in-
vertebrate vector is essential to the natural maintenance cycles
of many mosquito-borne viruses. Whether mosquito-borne viral
pathogens have evolved to encode VSRs, as have other viruses
with plant and insect hosts, has been unclear. Small RNAs are
important in modulating the pathogenesis of viral infections in
disease vector mosquitoes. Thus, infection of the invertebrate host
with a virus encoding a VSR could in theory result in a fitness cost
that would adversely affect the probability of the virus being
transmitted to a new vertebrate host. However, the results of the
present study indicate that flaviviruses encode at least one protein
capable of blocking RNAi in the mosquito, suggesting coevolution
of these viruses in response to the strong selective pressure exerted
by the RNA silencing pathways of the host, a classic “red queen
hypothesis.” Thus, a molecular arms race occurring between vector
and pathogen underlies the continued existence of these viruses in
nature, illustrating the importance of RNA silencing pathways in
the transmission of many important human diseases.
Materials and Methods
Mosquito Infections. Ae. aegypti (Liverpool) WT and dcr-2 null strains were
reared at 28 °C and 80% relative humidity, with a 14/10-h day/night light
cycle. Dcr-2 null mosquitoes were obtained as described previously (32).
Dcr-2 null mosquitoes were crossed with a previously described Ae. aegypti
“sensor” strain that expresses an eye-specific GFP reporter only when RNAi is
impaired (53). Dcr-2 null mosquitoes were screened at 6 d after emergence
for the expression of eye-specific GFP. Mosquitoes were injected with 0.5 μL
(106 pfu/mL) of recombinant SINV, and survival was monitored daily. The WT
mosquitoes were 2 d old at injection, whereas the dcr-2 null mosquitoes
were 8 d old due to the screening process.
Recombinant Virus Production. Recombinant SIN viruses were generated by
inserting heterologous sequences encoding known or suspected VSRs into a
multiple cloning site, located downstream of a duplicated subgenomic
promoter. Recombinant viruses were rescued as described previously (5).
RNA Isolation and Detection. Total RNAwas extracted from pools of mosquitoes
with Tri Reagent RT (Molecular Research Center) according to the manufac-
turer’s instructions. SINV mRNA levels were determined using a strand-specific
quantitative RT-PCR Taqman assay (Life Technologies) as described previously
(54), with the following primers and Taqman probe: forward, 5′-ATCACAA-
TTGGCAACGAGAAGAG-3′; reverse, 5′-CTGTGGGTTCGGAGAATAGTGG-3′; probe,
5′-CTAAAAGCAGCCGAACTC-3′. The following primers and Taqman probe were
used for YFV: forward, 5′-GGTTCCATGAGCGTGGCTAT-3′; reverse, 5′-GCGCAG-
CAGCGTAGTAACAC-3′; probe: 5′-CAAGCTGGAAGGTAGGGTGAT-3′. A minimum
of three independent biological replicates were tested, and results were
analyzed using the t test to determine significance.
Small RNA Library Preparation and Analysis. Libraries were prepared from
total RNA isolated with Tri RT (Molecular Research Center) from adult female
mosquitoes at 96 h after infection with recombinant SINVs. In brief, small
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RNAs (18–35-nt) were recovered by PAGE separation, and libraries were
prepared with the Truseq Small RNA Sample Preparation Kit (Illumina)
according to the manufacturer’s instructions. To reduce sources of nonbiological
variation, libraries were multiplexed and biological replicates were sequenced in a
single lane of a HiSeq (Illumina) flow cell. Following removal of the 3′ adapters,
10 million small RNA reads were selected at random from each dataset and
mapped to the SINV genome. Differential expression of vsiRNAs was determined
as described previously (55). The small RNA libraries used in this study are available
for download from the Gene Expression Omnibus (accession no. GSE80691).
Dicing Assays. Processing of long dsRNA into siRNAs was analyzed with an
ultra-active form of recombinant humanDicer, capable of cleavingmore than
95% of dsRNA template into siRNAs within 2 h (Genlantis), in an in vitro
cleavage assay. In brief, 32P-labeled dsRNA (700 bp, 30 ng) and recombinant
human Dicer (0.5 U) were incubated in the buffer solutions provided by the
manufacturer for 2 h at 37 °C, and then analyzed on a 15% PAGE gel. The
indicated concentrations of recombinant His-YFC protein, His-NS1 protein
(Bioclone), 6× His-tag peptide (Abcam), or recombinant GFP (Kerafast) were
coincubated in the dicing assay.
EMSA. EMSA was performed using the SYBR Green EMSA Kit (Life Technol-
ogies) according to the manufacturer’s instructions. In brief, a 200-bp dsRNA
or 21-bp siRNA duplex was incubated with various concentrations of re-
combinant proteins for 20 min at room temperature, and then visualized on
an agarose gel with SYBR Green.
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